Stockreport

A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Ozempic -- Novo's brand name for semaglutide -- has been around since 2017 as a diabetes treatment, but in mid-2021, the FDA first approved Novo's weekly injectable Weg [Read more]